Clinical Trials
4
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)TSN084 Treating Patients With Advanced Malignant Tumors
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Tyligand Bioscience (Shanghai) Limited
- Target Recruit Count
- 114
- Registration Number
- NCT06386705
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Peking university cancer hospital, Beijing, Beijing, China
A Study of TSN1611 Treating Patients with Advanced Solid Tumors Harboring KRAS G12D Mutation
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Target Recruit Count
- 150
- Registration Number
- NCT06385925
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸NEXT Oncology, San Antonio, Texas, United States
🇺🇸NEXT Virginia, Fairfax, Virginia, United States
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
Phase 1
Recruiting
- Conditions
- Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
- Interventions
- Drug: Phase II-Advanced melanomaDrug: Phase I dose escalationDrug: Phase II-HNSCCDrug: Phase II-solid tumors or lymphomas
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Tyligand Bioscience (Shanghai) Limited
- Target Recruit Count
- 162
- Registration Number
- NCT05842785
- Locations
- 🇨🇳
Fudan Cancer Hospital, Shanghai, Shanghai, China
Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Tyligand Bioscience (Shanghai) Limited
- Target Recruit Count
- 74
- Registration Number
- NCT05300438
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
News
No news found